# Phytochemical Composition and Mechanistic Pharmacology of Jerusalem Artichoke (Helianthus tuberosus L.): Implications for Functional and Therapeutic Applications

**Authors:** Dong-Hwan Kim, Wonmin Lee, Yeonhee Pyo, Dong-Kug Choi

PMC · DOI: 10.3390/cimb48020180 · 2026-02-05

## TL;DR

This paper reviews the health benefits of Jerusalem artichoke, focusing on its bioactive compounds and potential uses in food, medicine, and cosmetics.

## Contribution

The paper provides a comprehensive overview of Jerusalem artichoke's bioactive compounds and their health benefits, beyond just inulin.

## Key findings

- Jerusalem artichoke contains bioactive compounds like flavonoids and phenolic acids with antioxidant and anti-inflammatory effects.
- It shows potential in managing chronic diseases such as diabetes and cardiovascular disorders.
- JA benefits skin health and immune function by modulating gut microbiota.

## Abstract

Jerusalem artichoke (JA) (Helianthus tuberosus), a perennial plant of the Asteraceae family, is well known for its high inulin content and diverse bioactive compounds, including flavonoids, phenolic acids, sesquiterpenes, and amino acids. Extracts derived from different parts of JA, such as tubers, leaves, and flowers, have demonstrated a wide range of biological activities, including antioxidant, anti-inflammatory, antihyperglycemic, antihypertensive, and antifungal effects. These properties highlight JA’s potential in the prevention and management of chronic diseases such as diabetes, cardiovascular disorders, obesity, and colorectal cancer. Recent studies also suggest that JA benefits skin health through anti-aging and barrier-protective mechanisms and enhances immune function by modulating the intestinal microbiota. Owing to its multifunctional physiological activities, JA is being explored as a valuable raw material for food, nutraceutical, cosmetic, and pharmaceutical applications. However, most existing research has focused primarily on inulin, while comprehensive studies on other bioactive constituents and their clinical validation remain limited. This paper aims to provide a comprehensive overview of the bioactive compounds present in JA, elucidate their health-promoting functions, discuss their pharmacokinetics, and outline future perspectives on their potential as functional ingredients and biohealth materials.

## Linked entities

- **Chemicals:** sesquiterpenes (PubChem CID 139087999)
- **Diseases:** diabetes (MONDO:0005015), obesity (MONDO:0011122), colorectal cancer (MONDO:0005575)
- **Species:** Helianthus tuberosus (taxon 4233)

## Full-text entities

- **Genes:** Alb (albumin) [NCBI Gene 24186] {aka Alb1, Albza}, Il4 (interleukin 4) [NCBI Gene 16189] {aka BSF-1, Il-4}, Lipg (lipase G, endothelial type) [NCBI Gene 16891] {aka 3110013K01Rik, EL, lipase, mEDL}, Cr1l (complement C3b/C4b receptor 1 like) [NCBI Gene 12946] {aka Crry, Mcp, mCRY}, Dcn (decorin) [NCBI Gene 13179] {aka DC, DSPG2, PG40, PGII, PGS2, SLRR1B}, Sis (sucrase isomaltase) [NCBI Gene 69983] {aka 2010204N08Rik, SI, Si-s}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Irs2 (insulin receptor substrate 2) [NCBI Gene 384783] {aka Irs-2}, Slc17a5 (solute carrier family 17 (anion/sugar transporter), member 5) [NCBI Gene 235504] {aka 4631416G20Rik, 4732491M05, AST, ISSD, NSD, SD}, Anxa5 (annexin A5) [NCBI Gene 11747] {aka Anx5, CPB-I}, Got2 (glutamic-oxaloacetic transaminase 2) [NCBI Gene 25721] {aka ASPATA, mAAT}, Gpt (glutamic pyruvic transaminase, soluble) [NCBI Gene 76282] {aka 1300007J06Rik, 2310022B03Rik, ALT, ALT1, Gpt-1, Gpt1}, Lepr (leptin receptor) [NCBI Gene 16847] {aka B219, LEP-R, LEPROT, Leprb, Modb1, OB-RGRP}, Bche (butyrylcholinesterase) [NCBI Gene 12038] {aka C730038G20Rik}, Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}, p53-ps (Wistar clone pR53P1 p53 pseudogene) [NCBI Gene 301300], IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, Lta (lymphotoxin A) [NCBI Gene 16992] {aka LT, LT-[a], LT-alpha, LT[a], LTalpha, Ltx}, Pdlim3 (PDZ and LIM domain 3) [NCBI Gene 114108] {aka Actn2lp, Alp}, SI (sucrase-isomaltase) [NCBI Gene 6476], Tlr4 (toll-like receptor 4) [NCBI Gene 21898] {aka Lps, Ly87, Ran/M1, Rasl2-8}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, Bax (BCL2-associated X protein) [NCBI Gene 12028], IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Ccl5 (C-C motif chemokine ligand 5) [NCBI Gene 20304] {aka MuRantes, RANTES, SISd, Scya5, TCP228}, Nampt (nicotinamide phosphoribosyltransferase) [NCBI Gene 59027] {aka 1110035O14Rik, NAmPRTase, Pbef, Pbef1, Visfatin}, Ccl2 (C-C motif chemokine ligand 2) [NCBI Gene 20296] {aka HC11, JE, MCAF, MCP-1, MCP1, SMC-CF}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, Pck1 (phosphoenolpyruvate carboxykinase 1, cytosolic) [NCBI Gene 18534] {aka PEPCK, PEPCK-C, Pck-1}, NOX4 (NADPH oxidase 4) [NCBI Gene 50507] {aka KOX, KOX-1, RENOX}, Cat (catalase) [NCBI Gene 12359] {aka 2210418N07, Cas-1, Cas1, Cs-1}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Me1 (malic enzyme 1, NADP(+)-dependent, cytosolic) [NCBI Gene 17436] {aka D9Ertd267e, Mdh-1, Mod-1, Mod1}, Trp53-ps (transformation related protein 53, pseudogene) [NCBI Gene 22060], Gsk3b (glycogen synthase kinase 3 beta) [NCBI Gene 56637] {aka 7330414F15Rik, 8430431H08Rik, GSK-3, GSK-3beta, GSK3}, Nfkbia (nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha) [NCBI Gene 18035] {aka Nfkbi}, alp (alopecia, recessive) [NCBI Gene 11691], Cyp1a2 (cytochrome P450, family 1, subfamily a, polypeptide 2) [NCBI Gene 13077] {aka CP12, CYPIA2, P450-3}, Bax (BCL2 associated X, apoptosis regulator) [NCBI Gene 24887], Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 59086] {aka Tgfb}, App (amyloid beta precursor protein) [NCBI Gene 11820] {aka Abeta, Abpp, Adap, Ag, Cvap, E030013M08Rik}
- **Diseases:** rheumatism (MESH:D012216), insulin resistance (MESH:D007333), digestive disorders (MESH:D004066), joint pain (MESH:D018771), Toxicity (MESH:D064420), weight loss (MESH:D015431), metabolic, gastrointestinal, and immune-related disorders (MESH:D005767), immune deficiency (MESH:D007154), infection (MESH:D007239), impaired fasting glucose (MESH:D007003), cardiovascular disease (MESH:D002318), colon cancer (MESH:D015179), deaths (MESH:D003643), deficient (MESH:D007153), metastasis (MESH:D009362), pressure ulcers (MESH:D003668), arthritis (MESH:D001168), hepatic lipid abnormalities (MESH:D011017), necrosis (MESH:D009336), impaired glucose tolerance (MESH:D018149), liver dysfunction (MESH:D017093), tuberculosis (MESH:D014376), Dcn (MESH:C566452), adipose tissue (MESH:D018205), breast adenocarcinoma (MESH:D001943), T2DM (MESH:D003924), bacterial and Tuberculosis (TB) infections (MESH:D001424), edema (MESH:D004487), neuroinflammation (MESH:D000090862), lung injury (MESH:D055370), liver fibrosis (MESH:D008103), Diabetic (MESH:D003920), dysbiosis (MESH:D064806), lung damage (MESH:D008171), ear edema (MESH:D004427), Cancer (MESH:D009369), AD (MESH:D000544), non-alcoholic fatty liver disease (MESH:D065626), mitochondrial (MESH:D028361), skin disorders (MESH:D012871), pain (MESH:D010146), fibrosis decorin (MESH:D005355), 's disease (MESH:D004194), neurodegenerative conditions (MESH:D019636), injury to (MESH:D014947), hepatic disorders (MESH:D008107), Inflammation (MESH:D007249), colorectal adenocarcinoma (MESH:D003110), metabolic disorders (MESH:D008659), obesity (MESH:D009765)
- **Chemicals:** rifampicin (MESH:D012293), selenium (MESH:D012643), carbohydrates (MESH:D002241), MDA (MESH:D008315), fatty acid (MESH:D005227), phenols (MESH:D010636), riboflavin (MESH:D012256), urea (MESH:D014508), ethambutol (MESH:D004977), 8-epi-PGF2alpha (MESH:C075750), amino acid (MESH:D000596), nitrites (MESH:D009573), sodium selenite (MESH:D018038), butyrate (MESH:D002087), glycerin (MESH:D005990), oligosaccharides (MESH:D009844), potassium (MESH:D011188), JAP- (-), ent-kaur-16-en-19-oic acid (MESH:C014341), ozone (MESH:D010126), SCFA (MESH:D005232), heavy metals (MESH:D019216), calcium (MESH:D002118), ROS (MESH:D017382), glucose (MESH:D005947), chlorogenic acid (MESH:D002726), creatinine (MESH:D003404), skatole (MESH:D012862), flavonoids (MESH:D005419), magnesium (MESH:D008274), caffeic acid (MESH:C040048), cyanide (MESH:D003486), hydrogen (MESH:D006859), acetate (MESH:D000085), 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (MESH:C059087), sesquiterpenes (MESH:D012717), LPS (MESH:D008070), lipid (MESH:D008055), 2,2-azino-bis(3-ethylbenzothiazoline)-6-sulfonic acid (MESH:C002502), CO2 (MESH:D002245), fructose (MESH:D005632), fluoxetine (MESH:D005473), polyphenol (MESH:D059808), polymers (MESH:D011108), 7-aminoactinomycin D (MESH:C025942), triglyceride (MESH:D014280), 2,2-diphenyl-1-picrylhydrazyl (MESH:C004931), CCl4 (MESH:D002251), agar (MESH:D000362), caffeoylquinic acid (MESH:C472707), xylene (MESH:D014992), polysaccharide (MESH:D011134), lactate (MESH:D019344), bilirubin (MESH:D001663), carrageenan (MESH:D002351), ammonia (MESH:D000641), isoniazid (MESH:D007538), nitrates (MESH:D009566), sugars (MESH:D000073893), phosphorus (MESH:D010758)
- **Species:** Bifidobacterium (genus) [taxon 1678], Homo sapiens (human, species) [taxon 9606], Bacteroides (genus) [taxon 816], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Mycobacterium tuberculosis (species) [taxon 1773], Alternaria solani (species) [taxon 48100], Rattus norvegicus (brown rat, species) [taxon 10116], Staphylococcus aureus (species) [taxon 1280], Daucus carota (carrot, species) [taxon 4039], Panthera pardus (leopard, species) [taxon 9691], Respiratory syncytial virus (no rank) [taxon 12814], Helianthus tuberosus (Jerusalem artichoke, species) [taxon 4233], Drosophila melanogaster (fruit fly, species) [taxon 7227], Lactiplantibacillus plantarum (species) [taxon 1590], Blautia (genus) [taxon 572511], gut metagenome (species) [taxon 749906], Limosilactobacillus reuteri (species) [taxon 1598], Enterococcus faecium (species) [taxon 1352], Botrytis cinerea (gray fruit mold, species) [taxon 40559], Ananas comosus (pineapple, species) [taxon 4615], Enterobacteriaceae (enterobacteria, family) [taxon 543], Rhizoctonia solani (species) [taxon 456999], Oryctolagus cuniculus (domestic rabbit, species) [taxon 9986], Solanum tuberosum (potatoes, species) [taxon 4113], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Eubacterium coprostanoligenes (species) [taxon 290054], Nakaseomyces glabratus (species) [taxon 5478], Mus musculus (house mouse, species) [taxon 10090], Helianthus annuus (common sunflower, species) [taxon 4232], Escherichia coli (E. coli, species) [taxon 562], Glycine max (soybean, species) [taxon 3847], Malus domestica (apple, species) [taxon 3750], Clostridium perfringens (species) [taxon 1502], Candida albicans (species) [taxon 5476], Clostridia (class) [taxon 186801], Pediococcus pentosaceus (species) [taxon 1255], Megasphaera (genus) [taxon 906], Sus scrofa (pig, species) [taxon 9823], Cynara cardunculus var. scolymus (artichoke, varietas) [taxon 59895]
- **Cell lines:** HaCaT — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_0038), 264.7 — Homo sapiens (Human), Galactosemia, Finite cell line (CVCL_CX16), HT-29 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0320), 3T3 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0594), 3T3-L1 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0123), -L1 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z786), HT — Homo sapiens (Human), Diffuse large B-cell lymphoma germinal center B-cell type, Cancer cell line (CVCL_1290), MCF-7 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0031), RAW 264.7 — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493)

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12939966/full.md

---
Source: https://tomesphere.com/paper/PMC12939966